Wednesday 17th March 2021 |
Text too small? |
Rua Bioscience has successfully exported a sample of medicinal cannabis flower grown in Ruatorea to Germany. The sample of dried flower is similar to the product Rua aims to export in commercial quantities by the end of this year, as part of its sales agreement with German distributor, Nimbus Health. Though weighing just 70 grams, it has enabled the company to test its packaging and export processes.
Dr. Jessika Nowak, Rua’s Chief Research Officer, says this is the first time cannabis flower has been exported in any quantity from New Zealand to Germany and it has provided valuable early learning opportunities for all involved.
Once received by Nimbus Health, data from the temperature logger in the package was assessed to determine that the packaging performed as expected to keep the plant material at the required temperatures throughout shipping. The plant material was then sent on to a commercial laboratory in Germany for analytical testing.
Rua Bioscience CEO, Rob Mitchell, says this is a small, but important step for Rua in learning and understanding the export process, end to end. “Rua has a clear export strategy, and our first focus is on the German market. This sample export of dried medicinal cannabis flower to Germany gives us growing confidence that we are on the right track to export our commercial flower to Germany by the end of this year," says Mr Mitchell.
Please see the links below for details:
Announcement - Rua Bioscience exports first sample medicinal cannabis flower to Germany
Source: Rua Bioscience Limited
No comments yet
MNW - Senior management changes
June 19th Morning Report
GEN - Dividend Reinvestment Plan Strike Price
Scott Secures $27M in Global Contracts
June 18th Morning Report
June 17th Morning Report
PEB - Chair to Seek Re-Election; Director Nominations
Devon Funds Morning Note - 16 June 2025
TRU - Key Markets Update
THL receives unsolicited non-binding offer